Calculates a continuous infusion rate from total drug clearance and a target steady-state concentration. This guide explains the pharmacokinetic source, assumptions, safe unit handling, interpretation, monitoring and limitations.
Overview
Calculates a continuous infusion rate from total drug clearance and a target steady-state concentration.
Clinical Significance
The equation gives the rate required to maintain the selected concentration after distribution and equilibration, assuming stable linear clearance.
When to Use
- Use when the required concentration, timing and dosing information are reliable and the stated pharmacokinetic assumptions are reasonable.
- Use within an approved therapeutic-drug-monitoring or medicines-governance pathway.
- Use to support transparent review, not to automate prescribing.
How It Is Calculated
- Infusion rate = clearance × target steady-state concentration.
- MedicalC validates that all required inputs are numeric and rejects internally impossible time or concentration relationships where applicable.
Interpretation
- The equation gives the rate required to maintain the selected concentration after distribution and equilibration, assuming stable linear clearance.
- Interpret the result with the clinical indication, microbiology or seizure control, organ function, assay timing and local targets.
Worked Example
Enter a verified set of source values in the displayed units. MedicalC applies: Infusion rate = clearance × target steady-state concentration. Recheck the source chart and sampling times before using the result.
Patient Considerations
- Use only where a valid patient-specific clearance estimate and an evidence-based target concentration are available.
- Consider acute kidney injury, augmented renal clearance, fluid shifts, obesity, burns, pregnancy, critical illness and interacting medicines.
Limitations
- One-compartment equations may not describe distribution or multicompartment behaviour accurately.
- Derived values can appear precise despite uncertainty in sampling time, assay result and clearance stability.
- A calculated exposure or dose does not establish clinical benefit or safety.
Clinical Pearls
- Without a loading dose, the infusion rate determines the eventual steady state but not how quickly the target is reached.
- Plot concentrations against actual elapsed time before accepting any pharmacokinetic slope.
- When the result conflicts with the patient, verify the data rather than forcing a dose change.
Common Mistakes
- Using scheduled rather than actual administration and blood-sampling times.
- Treating a level drawn during distribution as a post-distribution concentration.
- Mixing mg/L, micrograms/mL and micrograms/L.
- Applying steady-state equations before steady state or during changing clearance.
- Using a generic concentration target outside the relevant indication or local protocol.
Evidence Base
Principal source: Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 4th ed.
Frequently Asked Questions
What does the Continuous Infusion Rate for Target Steady-State Concentration calculator estimate?
Calculates a continuous infusion rate from total drug clearance and a target steady-state concentration.
Can this result be used to prescribe automatically?
No. It requires clinician and pharmacist interpretation within a drug-specific protocol.
Why do actual administration and sample times matter?
Small timing errors can materially change an elimination slope, projected concentration or calculated exposure.
What should be checked after using the result?
Reassess concentration, organ function, fluid balance, extracorporeal clearance, clinical effect and toxicity after initiation and after any major physiological change.
When is a direct or Bayesian method preferable?
Use a validated Bayesian platform or direct free-level measurement when recommended, especially in complex or unstable patients.
References
- Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications. 4th ed. — Primary publication, consensus guideline or authoritative pharmacokinetic source.
Reviewed by: MedicalC Clinical Editorial Team
Last reviewed: July 2026
